Lakewood-Amedex Biotherapeutics announces annual shareholder meeting
LABT•Annual stockholder meeting and proposals
Lakewood-Amedex Biotherapeutics will hold its annual stockholder meeting virtually on September 22, 2026.
Shareholders will vote on electing four directors for one-year terms.
Ballots also cover increasing authorized common shares to 100,000,000 from 12,500,000.
Proposals include authorizing reverse stock splits up to a cumulative 1-for-20 ratio through September 22, 2027.
Other items include raising the 2020 equity plan share limit to 400,000, plus auditor ratification for 2026.
